"My favorite part of working at Genentech is getting to do collaborative, team-oriented science with highly skilled and driven scientists, all with a collective goal of improving human health."
My career at Genentech began in 2017 as a postdoctoral fellow in the Cancer Immunology department studying the cellular complexity of tumors. I quickly became interested in studying the role activated fibroblasts play in modulating the tumor microenvironment. In 2018 I transitioned to be a Principal Scientific Researcher as I was increasingly drawn toward learning how to leverage our basic science discoveries into potential therapeutic approaches and being part of the drug development pipeline. In 2021, I started my own research program as a Senior Scientist in the Cancer Immunology department to further our understanding of the interplay between stromal cells and immune cells in the context of cancer. Our hope is to leverage our findings to uncover novel biologies and develop innovative therapies for patients.
mmunological Review, 00, 1-22
Nature, 593, 575-579
Nature Immunology, 4, 369-380
My group’s research efforts are focused on further understanding the cellular and molecular mechanisms that regulate anti-tumor immunity and response to immunotherapy. We aim to integrate single cell multiomic technologies, in vivo pre-clinical models, genetic tools, imaging techniques, and clinical data to better understand these cellular interactions
Current areas of research include: